RE-SET is an educational resource about the biology of aging, skin and tissue changes, and current research involving GHK-Cu and Epitalon.
SCIENCE
INFORMS
HEALTHIER
TOMORROWS
KNOWLEDGE
SUPPORTS
INFORMED
CONVERSATIONS
Aging is a complex biological process influenced by many interconnected factors, including:
As we age, the skin and connective tissues undergo structural and functional changes involving collagen, elastin, hydration, and cellular turnover.
Most research is from laboratory, cellular, and animal studies.
Human clinical studies are limited in number and scope.
Changes in collagen, gene expression, or telomerase do not prove a substance reverses aging in humans.
High-quality, controlled human clinical trials are needed to establish safety and clinically meaningful outcomes.
Neither GHK-Cu nor Epitalon is an FDA-approved medication for reversing aging.
FDA identifies injectable GHK-Cu and Epitalon among bulk drug substances that may present significant safety risks in compounding, with limited human safety data.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed.
FDA distinguishes injectable GHK-Cu from non-injectable routes, which remain under evaluation. Regulatory status can change as new information becomes available.
https://www.fda.gov/drugs/human-drug-compounding
https://pubmed.ncbi.nlm.nih.gov
https://www.nih.gov
An educational monograph on the biology of aging, cellular senescence, telomere dynamics, dermal matrix remodeling, and current research involving GHK-Cu and Epitalon.
RE-SET is an educational resource about the biology of aging, skin and tissue changes, and current research involving GHK-Cu and Epitalon.
Aging is a complex biological process involving gradual changes in cells, tissues, organs, and physiological systems.
Researchers study many biological processes associated with aging, including cellular senescence, DNA and epigenetic changes, mitochondrial function, oxidative stress, inflammation, tissue remodeling, and changes in cellular signaling.
Research into these processes can improve understanding of aging biology, but evidence that a substance affects an aging-related pathway does not establish that it can reverse aging in humans.
Aging involves interconnected biological processes throughout the body. These can include:
These processes do not occur identically in every person. Genetics, nutrition, physical activity, sleep, sun exposure, tobacco use, medical conditions, medications, and other environmental factors can influence health as people age.
Skin provides a visible example of age-related biological changes. With aging, skin and connective tissues can undergo changes involving:
Both intrinsic aging and external factors such as ultraviolet exposure contribute to these changes. Research shows that aging can affect skin structure and the biological processes involved in tissue repair. PubMed
GHK-Cu is a naturally occurring copper-binding complex formed when the tripeptide glycyl-L-histidyl-L-lysine (GHK) binds copper.
GHK occurs naturally in the human body and has been investigated in relation to tissue remodeling, wound healing, inflammatory signaling, collagen production, and skin biology.
Published research has also investigated topical GHK-Cu and related peptides for cosmetic skin applications. PubMed
However, the amount and quality of clinical evidence varies significantly depending on the formulation and route of administration. A recent review found that despite widespread interest in GHK-Cu-containing anti-wrinkle products, published clinical evidence remains surprisingly limited. PubMed
Epitalon—also spelled Epithalon in some research—is a synthetic tetrapeptide composed of four amino acids. It has been investigated experimentally in relation to aging biology, cellular function, chromatin, telomeres, and telomerase.
Laboratory research published in 2025 reported increased telomere length in human cell lines and investigated mechanisms involving telomerase and alternative lengthening of telomeres. These were cell-line experiments, not evidence that Epitalon extends human lifespan or reverses aging in patients. PubMed
Earlier research also examined Epitalon's effects on chromatin in cultured cells obtained from older individuals. PubMed
These studies contribute to research into aging biology but do not establish Epitalon as a clinically proven anti-aging treatment.
Telomeres are protective structures located at the ends of chromosomes. They help maintain chromosome stability and generally become shorter as cells divide, although telomere biology varies among cell types and individuals.
Telomere length has therefore become an important area of aging research. However, aging is influenced by many biological processes and cannot be reduced to telomere length alone.
A substance demonstrating an effect on telomerase or telomeres in cultured cells does not establish that it slows or reverses aging in humans.
Research involving GHK-Cu and Epitalon spans different levels of evidence, including:
These forms of evidence should not be treated as equivalent. Laboratory findings can identify potentially interesting biological mechanisms, but they do not establish clinical effectiveness.
Likewise, demonstrating changes in collagen production, gene expression, telomerase activity, or another biological marker does not prove that a substance extends lifespan, prevents age-related disease, or reverses aging.
High-quality controlled human clinical trials are necessary to establish safety and clinically meaningful outcomes.
Healthy aging involves considerably more than any single biological pathway. Factors associated with overall health as people age include:
Individual health needs change with age and should be discussed with appropriate healthcare professionals.
Neither GHK-Cu nor Epitalon is an FDA-approved medication for reversing aging.
FDA currently identifies injectable GHK-Cu among bulk drug substances that may present significant safety risks. FDA notes limited human safety data and potential immunogenicity concerns associated with aggregation and peptide-related impurities. (U.S. Food and Drug Administration)
Importantly, FDA distinguishes injectable GHK-Cu from non-injectable routes. As of May 2026, GHK-Cu except for injectable routes is listed as a Category 1 bulk substance under evaluation, with FDA indicating that further advisory committee consideration is planned. (U.S. Food and Drug Administration)
FDA also identifies Epitalon among substances that may present significant safety risks in compounding. FDA states that it has not identified sufficient safety-related information for the proposed route of administration to determine whether Epitalon would cause harm in humans. (U.S. Food and Drug Administration)
FDA's 2026 evaluation also concluded that the available criteria weigh against adding Epitalon to the 503A Bulks List. (U.S. Food and Drug Administration)
These regulatory distinctions are important when evaluating claims about compounded peptide products.
Patients interested in healthy aging and peptide research may wish to ask:
Research into aging biology is rapidly evolving. Scientists continue to investigate cellular senescence, mitochondrial function, epigenetics, telomere biology, inflammation, tissue remodeling, regenerative processes, and many other mechanisms associated with aging.
GHK-Cu remains an area of interest in skin and regenerative research. A 2026 systematic review described promising regenerative, anti-inflammatory, and antioxidant findings, while also emphasizing the need for stronger standardized clinical evidence. PubMed
Epitalon continues to be investigated experimentally in areas including telomere biology and cellular aging, but laboratory findings should not be interpreted as evidence that it reverses aging or extends human lifespan.
Patients should distinguish among biological mechanisms, laboratory findings, human clinical evidence, cosmetic applications, and FDA-approved medical treatments when evaluating anti-aging claims.
This page is provided for general educational purposes only. It is not intended to provide medical advice, diagnosis, or treatment.
References to peptides, aging biology, telomeres, skin biology, biological mechanisms, laboratory research, animal studies, or areas of clinical investigation are provided for educational purposes and should not be interpreted as a recommendation or endorsement of a particular substance or treatment.
The terms “healthy aging,” “anti-aging,” or discussion of age-related biological processes should not be interpreted to mean that a substance has been demonstrated to stop or reverse human aging.
Discussion of an investigational substance does not establish that the substance is safe, effective, FDA-approved, or appropriate for medical use. Treatment decisions should be individualized and made with an appropriately licensed healthcare professional based on medical history, current health, medications, potential risks, available clinical evidence, and professional medical judgment.
FDA approval status, compounding policies, clinical evidence, and regulatory requirements may change. Current information should be verified through the U.S. Food & Drug Administration and other recognized medical resources.